Sex Hormone-binding Globulin is a Major Determinant of the Lipid Profile: the PRIME Study
Overview
Authors
Affiliations
The prevalence of coronary heart disease is much higher in men than in women and sex hormones might play a role in these differences through their influence on the lipid profile. The aim of this cross-sectional study was to study the relationship between hormonal markers (total testosterone (TT), estradiol (E2), sex-hormone-binding globulin (SHBG)) and plasma lipids in a population-based sample. Subjects were 352 men, 50-59 years old, selected in France (Lille, Strasbourg and Toulouse) and Northern-Ireland (Belfast) who had questionnaires and a medical examination at baseline of the PRIME prospective study (1991-1993). Pearson correlation coefficients and Student's t tests were used to identify factors associated with plasma lipids. Multiple linear regression models were used for multivariate analyses, using triglycerides (TG) (log-transformed) and high density-lipoprotein cholesterol (HDL-C) as dependent variables. SHBG and TT were negatively correlated with TG (p<0.0001 and p<0.05, respectively) and positively correlated with HDL-C (p<0.0001 and p<0.01). E2 was positively correlated with TG (p<0.05). No significant association was found between sex-hormones and LDL-C. In multiple linear regression analyses, SHBG remained independently associated negatively with TG (p<0.01) and positively with HDL-C (p<0.0001) after adjustment for centre of recruitment, age, body mass index, systolic blood pressure, smoking, alcohol intake and physical activity. After further adjustment for insulin, the association between SHBG and HDL-C remained highly significant (p<0.0001). The association between SHBG and TG was weakened but remained also significant. Our results suggest that SHBG might to be a central protein in the hormonal regulation of the lipid profile.
Yang J, Zhou J, Liu H, Hao J, Hu S, Zhang P Sci Rep. 2024; 14(1):11993.
PMID: 38796576 PMC: 11127952. DOI: 10.1038/s41598-024-62695-8.
Bourebaba L, Kepska M, Qasem B, Zyzak M, Lyczko J, Klemens M Front Mol Biosci. 2023; 10:1214961.
PMID: 38146533 PMC: 10749534. DOI: 10.3389/fmolb.2023.1214961.
Mohammadrezaei A, Mokhtari Ardekani A, Abbasalizad-Farhangi M, Mesgari-Abbasi M, Mousavi R Nutr Metab Insights. 2023; 16:11786388231155006.
PMID: 36860914 PMC: 9969450. DOI: 10.1177/11786388231155006.
Liang J, Zhang B, Hu Y, Na Z, Li D Front Endocrinol (Lausanne). 2023; 13:1119154.
PMID: 36726474 PMC: 9886494. DOI: 10.3389/fendo.2022.1119154.
Falcetta P, Benelli E, Molinaro A, Di Cosmo C, Bagattini B, Del Ghianda S J Endocrinol Invest. 2021; 44(12):2725-2733.
PMID: 34089497 PMC: 8572193. DOI: 10.1007/s40618-021-01594-5.